Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.
Li J, Wang J, Ibarra IL, Cheng X, Luecken MD, Lu J, Monavarfeshani A, Yan W, Zheng Y, Zuo Z, Colborn SLZ, Cortez BS, Owen LA, Wick B, Bao X, Haeussler M, Tran NM, Shekhar K, Sanes JR, Stout JT, Chen S, Li Y, DeAngelis MM, Theis FJ, Chen R. (2026) Single-cell atlas of the transcriptome and chromatin accessibility in the human retina. Nature genetics (Jan).
A phase 3 double-blind study to evaluate the efficacy and safety of oral ozanimod compared to oral fingolimod in children and adolescents with relapsing-remitting multiple sclerosis. Michael Dwyer, III (Co-Investigator). Bristol Myers Squibb. $1,649,376. 6/1/2023-12/1/2032.
Clinical and Translational Sciences Institute. Ram Samudrala (Co-Investigator). National Center for Advancing Translational Sciences. $28,400,000. 1/1/2026-12/1/2032.
CTSA State University of New York at Buffalo. Zackary Falls (Contributor). National Center for Advancing Translational Sciences (NCATS). $29,204,726. 1/1/2025-12/1/2031.
Clinical and Translational Science Award. Core Operations Special Populations. Ralph Benedict (Co-Investigator). NIH. $29,204,726. 1/1/2025-12/1/2031.
CTSA UM1 State University of New York at Buffalo. Bonnie Vest (Other). NIH. 1/1/2025-12/1/2031.
CTSA UM1 State University of New York at Buffalo. Praveen Chandrasekharan (Co-Investigator). NIH/NCATS. $29,204,726. 8/1/2025-7/1/2031.
CTSA UM1 State University of New York at Buffalo. Gabriela Popescu (Co-Investigator). National Center for Advancing Translational Sciences. $3,710,000. 1/1/2025-1/1/2031.
The UB Primary Care Training and Enhancement – Residency Training in Street Medicine. Brian Clemency (Co-Investigator). HRSA. $2,500,000. 9/1/2025-9/1/2030.
Structure and assembly of membrane proteins at tight junctions. Alex Vecchio (Principal Investigator). NIH/NIGMS. $2,166,105. 9/1/2025-8/1/2030.
Revolutionizing Protein Structure Determination with Advanced SWAXS Analysis. Thomas Grant (Principal Investigator). NIH NIGMS. $2,181,805. 8/1/2025-7/1/2030.
Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion. Xiaozhong Wen (Principal Investigator). National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development. $3,361,314. 8/1/2025-7/1/2030.
CTSA K12 Program State University of New York at Buffalo. Praveen Chandrasekharan (Co-Investigator). NIH/NCATS. $3,269,012. 6/1/2025-7/1/2030.
Prevention of Postpartum Smoking Relapse and Related Health Consequences through Breastfeeding Promotion. Praveen Chandrasekharan (Co-Principal Investigator). NICHD. $3,841,280. 8/1/2025-7/1/2030.
Impact of polymicrobial interactions and within-host adaptation on CAUTI pathogenesis. Chelsie Armbruster (Principal Investigator). NIDDK. $3,693,751. 7/1/2025-6/1/2030.
Impact of “Institutions for Mental Diseases” (IMD) Medicaid waivers on opioid use disorder treatment outcomes: A Mixed Methods Approach to Identify Strategies that Improve Utilization and Quality of Care and Promote Equity in Treatment. Heather Gardiner (Other). NIH. $945,788. 7/1/2025-6/1/2030.